权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL

CLL 中癌基因失调/抑癌基因丢失

基本信息

批准号：
6633289
负责人：
CARLO M CROCE
金额：
$ 159万
依托单位：
THOMAS JEFFERSON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
起止时间：
1999-07-27 至 2004-09-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6633289
关键词：
chronic lymphocytic leukemia neoplasm /cancer genetics oncogenes tumor suppressor genes

项目摘要

This program project focuses on the molecular mechanisms and the genes involved in the pathogenesis and progression of B- and T-cell chronic lymphocytic leukemia. It consists of four related and highly interdependent projects and two core facilities. Project 1 concerns the role of BCL2 and TCL1 in the pathogenesis of B-CLL and T-CLL respectively. We propose to investigate the mechanisms of up-regulation of BCL2 in B-CLL and the mechanisms of action of TCL1 in T-CLL. We propose to investigate the mechanisms of up-regulation of BCL2 in B- CLL and the mechanisms of action of TCL1 in T-CLL. We also propose to identify the role of other genes that are involved in the progression of B- and T-CLL. The second project focuses on the use of the positional cloning approach to clone a gene at 13q14.3 that is involved in deletions in most human B-CLLs. We have already sequenced over 750 Kb of the critical chromosomal region and are testing candidate genes for mutations and deletion in B-CLL The third project focuses on the use of Tcll knock out mice to assess the role of Tcll in lymphoid development. In addition this project proposes to investigate the cooperation of TCL1 deregulation and ATM loss of function in leukemogenesis. The fourth project focuses on the tridimensional characterization of Tcll and Mtcpl and their mutants and on the interaction of these two oncoproteins with other proteins. The two core facilities, administrative, and protein chemistry, provide outstanding core support for the scientific activities described in the proposal.

本项目主要研究B细胞和t细胞慢性淋巴细胞白血病发病和进展的分子机制和相关基因。它由四个相关且高度相互依存的项目和两个核心设施组成。项目1分别关注BCL2和TCL1在B-CLL和T-CLL发病机制中的作用。我们拟探讨BCL2在B-CLL中的上调机制和TCL1在T-CLL中的作用机制。我们拟探讨BCL2在B- CLL中的上调机制和TCL1在T-CLL中的作用机制。我们还建议确定参与B-和T-CLL进展的其他基因的作用。第二个项目侧重于使用位置克隆方法克隆13q14.3基因，该基因与大多数人类b - cll中的缺失有关。我们已经对超过750 Kb的关键染色体区域进行了测序，并正在测试B-CLL突变和缺失的候选基因。第三个项目侧重于使用Tcll敲除小鼠来评估Tcll在淋巴细胞发育中的作用。此外，本项目拟探讨TCL1解除调控与ATM功能丧失在白血病发生中的合作关系。第四个项目重点研究Tcll和Mtcpl及其突变体的三维特征，以及这两种癌蛋白与其他蛋白的相互作用。两个核心设施，行政设施和蛋白质化学设施，为提案中描述的科学活动提供了出色的核心支持。

项目成果

期刊论文数量（48）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Structure of murine Tcl1 at 2.5 A resolution and implications for the TCL oncogene family.

2.5 A 分辨率下的鼠 Tcl1 结构及其对 TCL 癌基因家族的影响。

DOI：
10.1107/s090744490101352x
发表时间：
2001
期刊：
Acta crystallographica. Section D, Biological crystallography
影响因子：
0
作者：
Petock,JM;Torshin,IY;Wang,YF;DuBois,GC;Croce,CM;Harrison,RW;Weber,IT
通讯作者：
Weber,IT

Close pairs of carboxylates: a possibility of multicenter hydrogen bonds in proteins.

紧密的羧酸盐对：蛋白质中多中心氢键的可能性。

DOI：
10.1093/proeng/gzg027
发表时间：
2003
期刊：
Protein engineering
影响因子：
0
作者：
Torshin,IvanY;Harrison,RobertW;Weber,IreneT
通讯作者：
Weber,IreneT

Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene.

DOI：
发表时间：
2001-09
期刊：
Cancer research
影响因子：
11.2
作者：
F. Bullrich;H. Fujii;G. Calin;H. Mabuchi;M. Negrini;Y. Pekarsky;L. Rassenti;H. Alder;John Calvin Reed;M. Keating;T. Kipps;C. Croce
通讯作者：
F. Bullrich;H. Fujii;G. Calin;H. Mabuchi;M. Negrini;Y. Pekarsky;L. Rassenti;H. Alder;John Calvin Reed;M. Keating;T. Kipps;C. Croce

Net charge center as the simplest model of a protein identifies up to 100% of active/binding site residues.

Net%20charge%20center%20as%20the%20simplest%20model%20of%20a%20蛋白质%20识别%20up%20to%20100%%20of%20活性/结合%20位点%20残基。